Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive examination. Proponents often highlight the potential for significant therapeutic outcomes, principally in conditions where conventional treatments have proven limited. However, crucially important to consider the substantial financial investment associated wi